Thoracic surgeon Dr. Michaela Straznicka MD, FACS, from BASS Medical Group highlights exciting advancements in lung cancer treatment. Discover how understanding cancer mutations, immunotherapy, new radiation techniques, and minimally-invasive surgeries, including robotic-assisted procedures, have transformed patient care.
Some of the most exciting advancements in lung cancer care involve specialized treatment options that continue to evolve. Forty years ago, a cancer diagnosis was simply that—cancer. Then, 30 years ago, we discovered that there were different types of cancer. Now, within those subtypes, we are identifying mutations on cancer cells that help guide treatment. One major breakthrough is immunotherapy, which allows the body's own immune system to help fight cancer. Additionally, new radiation treatments are designed to protect as much healthy lung tissue as possible while still effectively targeting cancer cells. Surgical advancements are also exciting. We now have minimally invasive biopsy options that sometimes require no incision at all. Minimally invasive surgical techniques mean smaller incisions, avoiding the need to cut muscles or bones. Robotics play a significant role in modern surgery, allowing for faster procedures, shorter hospital stays, and quicker recoveries. Patients are returning to their normal activity levels much sooner than ever before. Overall, the landscape of lung cancer care has changed dramatically—even within my own career. But despite these advancements, lung cancer remains a silent killer, making early detection and aggressive treatment critical for high-risk patients. My name is Michaela Straznicka, and I am a proud member of the BASS Medical Group.
